BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23453756)

  • 1. [Brachytherapy dose calculation].
    Ferré M; Mailleux H; Pierrat N; Dejean C
    Cancer Radiother; 2013 Apr; 17(2):89-92. PubMed ID: 23453756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAPM TG-43 formalism for brachytherapy dose calculation of a 137Cs tube source.
    Zhang P; Beddar AS; Sibata CH
    Med Phys; 2004 Apr; 31(4):755-9. PubMed ID: 15124992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
    Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric characteristics of the CDC-type miniature cylindrical 137Cs brachytherapy sources.
    Pérez-Calatayud J; Ballester F; Serrano-Andrés MA; Lluch JL; Puchades V; Limami Y; Casal E
    Med Phys; 2002 Apr; 29(4):538-43. PubMed ID: 11991125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
    Poon E; Williamson JF; Vuong T; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
    Duggan DM
    Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detailed dose distribution prediction of Cf-252 brachytherapy source with boron loading dose enhancement.
    Ghassoun J; Mostacci D; Molinari V; Jehouani A
    Appl Radiat Isot; 2010 Feb; 68(2):265-70. PubMed ID: 19889549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-specific Monte Carlo-based dose-kernel approach for inverse planning in afterloading brachytherapy.
    D'Amours M; Pouliot J; Dagnault A; Verhaegen F; Beaulieu L
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1582-9. PubMed ID: 21075547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple modification of TG-43 based brachytherapy dosimetry with improved fitting functions: application to the selectSeed source.
    Juan-Senabre XJ; Porras I; Lallena AM
    Phys Med; 2013 Jun; 29(4):403-11. PubMed ID: 22698855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancements to commissioning techniques and quality assurance of brachytherapy treatment planning systems that use model-based dose calculation algorithms.
    Rivard MJ; Beaulieu L; Mourtada F
    Med Phys; 2010 Jun; 37(6):2645-58. PubMed ID: 20632576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo dosimetric study of the BEBIG Co-60 HDR source.
    Ballester F; Granero D; Pérez-Calatayud J; Casal E; Agramunt S; Cases R
    Phys Med Biol; 2005 Nov; 50(21):N309-16. PubMed ID: 16237230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technical note: fitted dosimetric parameters of high dose-rate 192Ir sources according to the AAPM TG43 formalism.
    Lliso F; Pérez-Calatayud J; Carmona V; Ballester F; Puchades V; Granero D
    Med Phys; 2003 Apr; 30(4):651-4. PubMed ID: 12722817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of brachytherapy treatment planning.
    Rivard MJ; Venselaar JL; Beaulieu L
    Med Phys; 2009 Jun; 36(6):2136-53. PubMed ID: 19610303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
    Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
    Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monte Carlo dosimetric characterization of the Cs-137 selectron/LDR source: evaluation of applicator attenuation and superposition approximation effects.
    Pérez-Calatayud J; Granero D; Ballester F; Puchades V; Casal E
    Med Phys; 2004 Mar; 31(3):493-9. PubMed ID: 15070245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brachytherapy scatter dose calculation in heterogeneous media: II. Empirical formulation for the multiple-scatter contribution.
    Wang R; Sloboda RS
    Phys Med Biol; 2007 Sep; 52(18):5637-54. PubMed ID: 17804886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose verification with Monte Carlo technique for prostate brachytherapy implants with (125)I sources.
    Zhang H; Baker C; McKinsey R; Meigooni A
    Med Dosim; 2005; 30(2):85-91. PubMed ID: 15922174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose distribution for endovascular brachytherapy using Ir-192 sources: comparison of Monte Carlo calculations with radiochromic film measurements.
    Sureka CS; Sunny CS; Subbaiah KV; Aruna P; Ganesan S
    Phys Med Biol; 2007 Jan; 52(2):525-37. PubMed ID: 17202631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameterization of brachytherapy source phase space file for Monte Carlo-based clinical brachytherapy dose calculation.
    Zhang M; Zou W; Chen T; Kim L; Khan A; Haffty B; Yue NJ
    Phys Med Biol; 2014 Jan; 59(2):455-64. PubMed ID: 24374831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-Based Dose Calculation Algorithms for Brachytherapy Dosimetry.
    Enger SA; Vijande J; Rivard MJ
    Semin Radiat Oncol; 2020 Jan; 30(1):77-86. PubMed ID: 31727303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.